TVTXTravere Therapeutics, Inc.ToppingEarnings in 2 days

TodayTopping

Nasdaq GMBiotechnologyMarket cap $4.65BReports Oct 29, 2026

Travere Therapeutics, Inc.

Rare disease
Sector
Healthcare
Industry
Biotechnology
Market cap
$4.65B
Employees
497
Exchange
Nasdaq GM
Country
United States
49.97−0.22% todayClose of Oct 26, 2026 · end-of-day snapshot

Not sure what's inside? Read a full TSLA analysis, currently free

Figures as of Oct 26, 2026Unlock all 8$9.90one-time

Technical readingsFree

Trend state Topping, stage 3 of 4, 1 of 4 damage flags raised (as of Oct 26, 2026)

Automated read

Price is trading above its key moving averages and momentum readings are contained: the mid-term picture reads as an orderly uptrend. RSI is currently 27.

Readings, end-of-day Oct 26, 2026
RSI (14)Oversold zone26.59, flagged reading
MACD / signalBelow signal line-3.03 / -2.54, caution reading
SMA 50Price below61.37, caution reading
SMA 200Price above45.82, favorable reading
EMA 20Price below55.80, caution reading
ADX (14)Trending32.72
Show all 12 readings
+DI / −DI−DI leading15.95 / 31.40, caution reading
ATR (14)4.7% of price — typical daily swing2.37
Stochastic %KOversold zone1.13, flagged reading
Bollinger bands (20)Inside bands48.46 – 64.33
ROC (10)Negative over 10 sessions-12.88, caution reading
Trend / momentum impulseTrend and momentum agreeBoth falling, caution impulse reading
Full analysis

What unlocking TVTX reveals

Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock
Signal historyEvery past volume signal measured forward from the day it fired.Generated on unlock
AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock
Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock
Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock

Generated on unlock: written when TVTX's analysis runs, rather than checked against its stored data now.

Every section above, argued on TVTX's own numbers, on one page.

See what TVTX costsNot sure what's inside? Read a full TSLA analysis, currently free

Unlock the full TVTX analysis

AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.

  • Unlocked in about 60 seconds
  • No account needed
  • Secure checkout via Stripe

Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.

Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get TVTX + ~23,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
Earnings

When does Travere Therapeutics, Inc. report earnings?

Travere Therapeutics, Inc. (TVTX) is scheduled to report earnings on Oct 29, 2026.

The date is confirmed rather than estimated, though companies do occasionally reschedule.

Data as of Oct 27, 2026

See who else reports soon
Data dictionary
$9.90one-time Unlock TVTX